Pharmacyclics Inc (PCYC) 254.22 $PCYC Jim Cramer's 'Mad

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pharmacyclics Inc (PCYC) 254.22 $PCYC

Jim Cramer's 'Mad Money' Recap: Why Aren't Well-Run Companies Getting Respect?
at The Street - 1 hr 39 mins ago
Cramer says what seems overvalued on paper today might surprise you and be in a whole new category tomorrow.
BID: 41.73 (-0.02), TSLA: 200.63 (-1.80), GWRE: 53.04 (-0.33), ZIOP: 13.81 (+0.47), GE: 25.82 (+0.16), LMT: 199.10 (+0.13), PCYC: 254.22 (+23.74), BX: 39.14 (+0.53), BMRN: 113.50 (+3.71), UTX: 120.79 (-0.25), HZO: 25.43 (+0.35), XOM: 86.74 (-0.44), CZR: 10.16 (-0.20), SBUX: 93.63 (+0.57), ETP: 58.05 (-0.20), SSYS: 64.31 (+2.44), RCPT: 141.19 (+13.19), COST: 151.17 (+4.00), ABBV: 56.86 (-3.41), TRAK: 40.72 (+0.64), ROL: 34.00 (+0.09), OA: 67.75 (-0.45), MOV: 24.45 (-0.19), MBLY: 37.02 (+2.21), CSCO: 29.30 (-0.03), URI: 92.06 (-0.28), CTRL: 12.42 (-0.12), AMZN: 387.83 (+5.11), GPRO: 41.08 (-1.93), KR: 74.31 (+4.66), WFC: 54.84 (+0.02), NXPI: 98.67 (-0.80), BMY: 66.05 (+0.38), BA: 154.47 (+0.12), HPQ: 34.00 (-0.19), DRI: 64.21 (+1.32), ISIS: 71.76 (+1.60), MCD: 99.11 (-1.14), CVX: 104.73 (-0.43), BABA: 86.10 (+0.61)

Irish Highlanders: Drug Stocks Mallinckrodt, Horizon Pharma Rally
at Investor's Business Daily - Thu Mar 05, 5:32PM CST
Drugmakers seized market headlines Thursday when Pharmacyclics (PCYC) spiked 10% on word that it would be acquired by AbbVie (ABBV) in a $21 billion cash and stock deal. The news sent AbbVie down 5% in heavy trade, but also launched a mild rally...
MNK: 121.70 (+5.51), PCYC: 254.22 (+23.74), TARO: 152.07 (+0.24), HZNP: 20.84 (-0.33), ABBV: 56.86 (-3.41), ICLR: 67.84 (+0.12)

Nasdaq stocks posting largest volume increases
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
SFST: 16.60 (-0.28), PCYC: 254.22 (+23.74), KYTH: 50.00 (+10.10), HWBK: 13.92 (+0.03), EML: 19.54 (-0.18), CNDO: 3.37 (+0.14), XPLR: 6.08 (-0.14), BOBE: 47.76 (+1.40), NWFL: 28.68 (+0.02), DJCO: 201.70 (+1.49), TSRI: 4.87 (-0.20), HTWO: 10.14 (-0.15)

Most active Nasdaq-traded stocks
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 29.28 (+0.02), PCYC: 254.22 (+23.74), FB: 81.21 (+0.32), INTC: 33.73 (-0.39), OREX: 8.01 (-0.48), FOX: 34.03 (-0.04), GERN: 3.78 (+0.97), FOXA: 34.87 (-0.10), MSFT: 43.11 (+0.05), ZNGA: 2.41 (+0.02), AAPL: 126.41 (-2.13), CSCO: 29.30 (-0.03)

AbbVie Stock Slides On Pricey Pharmacyclics Deal
at Investor's Business Daily - Thu Mar 05, 3:56PM CST
Big pharma AbbVie's $21 billion deal to acquire hot biotech Pharmacyclics was met with widespread skepticism by AbbVie investors Thursday, sending AbbVie's stock falling 5.7% Thursday. AbbVie (ABBV) announced the cash-and-stock acquisition late...
JNJ: 102.52 (+0.87), PCYC: 254.22 (+23.74), PFE: 34.47 (-0.17), AMGN: 159.60 (+0.41), ABBV: 56.86 (-3.41), NVS: 98.95 (-0.09)

Stocks Notch Small Gains Ahead of February Jobs Report
at The Street - Thu Mar 05, 3:43PM CST
Stocks manage to close with gains on Thursday, but just barely ahead of the February jobs report on Friday
PCYC: 254.22 (+23.74), C: 53.56 (-0.11), WYNN: 139.00 (+0.18), BAC: 16.00 (+0.16), LVS: 56.36 (-0.64), JNJ: 102.52 (+0.87), GS: 190.08 (+0.41), JPM: 62.00 (-0.13), MPEL: 24.17 (-0.77), COST: 151.17 (+4.00), ABBV: 56.86 (-3.41), AAPL: 126.41 (-2.13)

AbbVie and Costco are big market movers
AP - Thu Mar 05, 3:35PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
AMBA: 64.39 (-3.10), PCYC: 254.22 (+23.74), COST: 151.17 (+4.00), BOBE: 47.76 (+1.40), PEIX: 11.75 (+2.42), SMTC: 26.30 (-2.99), SWHC: 14.40 (+0.06)

Stocks Rise From Pullback; Pharmacyclics Jumps On Buyout News
at Investor's Business Daily - Thu Mar 05, 3:24PM CST
Stocks rose for the first time in three sessions Thursday, amid mixed economic data and news that the European Central Bank will start its quantitative easing soon. The Nasdaq rose 0.3%, while the Dow Jones industrial average edged up 0.2% and the...
SPLS: 16.50 (-0.09), MNK: 121.70 (+5.51), PCYC: 254.22 (+23.74), MIDD: 104.46 (+3.15), ABBV: 56.86 (-3.41), FL: 57.03 (-0.46), BIG: 47.82 (+0.41)

The Under-the-Radar Reason Why Puma Biotechnology Inc. Rocketed 17% Higher
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 05, 2:15PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Puma Biotechnology , a clinical-stage...
PCYC: 254.22 (+23.74), ABBV: 56.86 (-3.41), PBYI: 243.17 (+36.21)

Stocks' Gains Are Limited in Lead-Up to February Jobs Report
at The Street - Thu Mar 05, 2:10PM CST
Stocks regain positive momentum by mid-afternoon. Weaker-than-expected domestic data and the materials sector kept gains limited.
JOY: 39.94 (-2.19), XLB: 51.15 (-0.22), PCYC: 254.22 (+23.74), KR: 74.31 (+4.66), C: 53.56 (-0.11), WYNN: 139.00 (+0.18), BAC: 16.00 (+0.16), LVS: 56.36 (-0.64), TWX: 83.26 (+0.18), GS: 190.08 (+0.41), CPE: 7.16 (-0.29), JPM: 62.00 (-0.13), ANF: 20.21 (-0.06), MPEL: 24.17 (-0.77), COST: 151.17 (+4.00), ABBV: 56.86 (-3.41), AAPL: 126.41 (-2.13)

Stocks Turn Positive; Embraer Falls On Weak Earnings
at Investor's Business Daily - Thu Mar 05, 2:00PM CST
Stocks were modestly higher with an hour to go in Thursday's session as investors weighed mixed U.S. economic data and new European Central Bank stimulus. The Nasdaq was up 0.3%, the Dow Jones industrial average climbed 0.2% and the S&P 500 edged up...
MNK: 121.70 (+5.51), JOY: 39.94 (-2.19), AMBA: 64.39 (-3.10), PCYC: 254.22 (+23.74), ERJ: 33.33 (-1.57), QLYS: 49.74 (+2.26), ABBV: 56.86 (-3.41)

Stocks Nearly Flat In Afternoon; Qualys Climbs To New High
at Investor's Business Daily - Thu Mar 05, 12:30PM CST
Stocks were flat Thursday afternoon as investors weighed mixed U.S. economic data and new stimulus efforts by the European Central Bank. The Nasdaq and the Dow Jones industrial average were both flat, while the S&P 500 slipped 0.1%. All three indexes...
JOY: 39.94 (-2.19), PCYC: 254.22 (+23.74), SFM: 35.19 (+0.46), QLYS: 49.74 (+2.26), ABBV: 56.86 (-3.41)

Nasdaq stocks posting largest percentage increases
AP - Thu Mar 05, 12:29PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
HYGS: 14.78 (+1.02), DVAX: 21.56 (+0.25), PCYC: 254.22 (+23.74), HYG.TO: 18.50 (+1.45), ATRA: 28.75 (+2.20), CECO: 6.00 (unch), OREX: 8.01 (-0.48), EVOK: 6.03 (+0.61), PRQR: 21.37 (+1.88), FCSC: 5.94 (+0.29), KYTH: 50.00 (+10.10), ATTU: 10.43 (+1.05), MRTX: 26.65 (+2.25), PEIX: 11.75 (+2.42)


AbbVie to buy leukemia drugmaker Pharmacyclics for $21B
By TOM MURPHY - AP - Thu Mar 05, 12:17PM CST
AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics and add another major revenue producer to a portfolio that already includes the world's top-selling drug.
PCYC: 254.22 (+23.74), AMGN: 159.60 (+0.41)

Geron gets boost from AbbVie-Pharmacyclics deal
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 11:15AM CST

JNJ: 102.52 (+0.87), PCYC: 254.22 (+23.74), GERN: 3.78 (+0.97), ABBV: 56.86 (-3.41)

Stocks Higher At Noon; Costco, Middleby Rebound
at Investor's Business Daily - Thu Mar 05, 11:03AM CST
Stocks were modestly higher at midday Thursday following a large acquisition in the health care sector and bullish comments by the European Central Bank. The Nasdaq was up 0.4%, the Dow Jones industrial average gained 0.3% and the S&P 500 climbed...
PCYC: 254.22 (+23.74), MIDD: 104.46 (+3.15), ABBV: 56.86 (-3.41), BITA: 73.46 (+5.22)

Mallinckrodt Stock Hits High On Ikaria Buyout
at Investor's Business Daily - Thu Mar 05, 10:52AM CST
Specialty drugmaker Mallinckrodt (MNK) announced a $2.3 billion deal Thursday to acquire privately held Ikaria, which was greeted with enthusiasm on the stock market. Ikaria makes INOmax, an inhaled nitric oxide used to treat newborns with...
MNK: 121.70 (+5.51), PCYC: 254.22 (+23.74), ABBV: 56.86 (-3.41)

How These Healthcare Megadeals Helped Send the Market Higher
Dan Caplinger, The Motley Fool - Motley Fool - Thu Mar 05, 10:03AM CST
AbbVie made a big purchase overnight. Source: AbbVie. As the stock market has climbed, many investors have become increasingly concerned about whether its gains are sustainable. One key signal that can determine whether stocks are overpriced comes...
MNK: 121.70 (+5.51), PCYC: 254.22 (+23.74), ABBV: 56.86 (-3.41)

Pharmacyclics (PCYC) Stock Spikes Today Following $21 Billion AbbVie Merger Deal
at The Street - Thu Mar 05, 9:56AM CST
Pharmacyclics (PCYC) shares are up double digits after the company announced that it was purchased by AbbVie (ABBV) for $21 billion.
PCYC: 254.22 (+23.74)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 3

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 11

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 5

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Real Estate Investing: Rockwood Capital and HSAM

Updated Category News Views 513

Rockwood Capital Integrates with Harrison Street In a significant move for the real estate investment sector, Rockwood Capital, a renowned firm in the private real estate investment arena, has announced its integration into Harrison Street Asset Management (HSAM). This union marks the beginning of a new chapter, promising enhanced offerings for both companies and their...

Continue Reading
Benitec Biopharma's Q1 2025 Update: Encouraging Study Results

Updated Category News Views 122

Benitec Biopharma's First Quarter 2025 Financial Highlights and Clinical Progress Benitec Biopharma Inc. (NASDAQ: BNTC) is making strides in the world of biotechnology focused on developing gene therapies. The company recently released its financial results for the first fiscal quarter ending September 30, 2024, alongside significant updates on its clinical programs. In a...

Continue Reading
Faraday Future Partners for the Inaugural Hanlin Cup Golf Classic

Updated Category News Views 275

Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) made a strategic move back in 2024, linking up with the inaugural US-Canada Hanlin Cup Golf Classic. This collaboration was about more than just golf; it aimed to enhance brand visibility for Faraday's upscale Faraday X (FX) line. You see, in an industry where every edge counts, aligning with high-profile events like...

Continue Reading
The Rise of Digital Services in Global Trade Dynamics

Updated Category News Views 275

The Rise of Digital Services in Global Trade Dynamics Digital services are increasingly becoming focal points in the complexities of global trade. As economies evolve, the significance of these services, including cloud storage and financial applications, is rising swiftly. According to analyses from leading consulting firms, the trade of services will see an impressive...

Continue Reading
Old Dominion Freight Line Prepares for Q3 2024 Earnings Call

Updated Category News Views 67

When it comes to freight, Old Dominion Freight Line (Nasdaq: ODFL) has built a formidable reputation. The third quarter earnings call is just around the corner, slated for a Wednesday morning, which many in the finance world are eyeing with anticipation. Investors want the juicy details—how has ODFL performed over the last three months? What’s next for this player in...

Continue Reading